Literature DB >> 16750243

Effects of time and point-of-use devices on arsenic levels in Southeastern Michigan drinking water, USA.

Melissa J Slotnick1, Jaymie R Meliker, Jerome O Nriagu.   

Abstract

Health effects associated with chronic, low-level exposures to arsenic in drinking water (<100 microg/L) remain unclear, in part due to uncertainties in assessing exposure. Drinking water concentrations have been used to assess past exposure to arsenic in epidemiological studies, under the assumption that a single measurement can be used to estimate historical exposure. This study aims to better understand (1) temporal variability in arsenic concentrations in drinking water and (2) the impact of point-of-use (POU) treatment devices on arsenic exposure measurements, and on reliability of the exposure measurement for population-level studies. Multiple drinking water samples were collected at two points in time (an average of fourteen months apart) for 261 individuals enrolled in a case-control study of arsenic exposure and bladder cancer in Michigan. Sources of drinking water included private wells (n = 221), public water supplies (n = 33), and bottled water (n = 7); mean arsenic concentration was highest in private wells (7.28 microg/L) and lowest in bottled water samples (0.28 microg/L). Arsenic concentrations in primary drinking water samples were highly correlated (r = 0.88, p < 0.0001, n = 196), with 3% of the water sources exceeding the United States Environmental Protection Agency's Maximum Contaminant Level (MCL) in one sample but not in the other sample. Measurement reproducibility did not vary by type of POU device (e.g., softener, filter, reverse osmosis system). Arsenic concentrations did differ, however, between samples treated with POU devices and untreated samples taken on the same day. Substantial differences in arsenic concentrations were consistently observed for reverse osmosis systems; other POU devices had variable effects on arsenic concentrations. These results indicate that while a single residential arsenic measurement may be used to represent exposure in this region, researchers must obtain information on changes in water source and POU treatment devices to better characterize population exposures over time.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16750243     DOI: 10.1016/j.scitotenv.2006.04.021

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  16 in total

1.  Investigating causal relation between prenatal arsenic exposure and birthweight: Are smaller infants more susceptible?

Authors:  Mohammad L Rahman; Linda Valeri; Molly L Kile; Maitreyi Mazumdar; Golam Mostofa; Qazi Qamruzzaman; Mahmudur Rahman; Andrea Baccarelli; Liming Liang; Russ Hauser; David C Christiani
Journal:  Environ Int       Date:  2017-08-05       Impact factor: 9.621

2.  Incorporating individual-level distributions of exposure error in epidemiologic analyses: an example using arsenic in drinking water and bladder cancer.

Authors:  Jaymie R Meliker; Pierre Goovaerts; Geoffrey M Jacquez; Jerome O Nriagu
Journal:  Ann Epidemiol       Date:  2010-10       Impact factor: 3.797

Review 3.  Health Effects and Environmental Justice Concerns of Exposure to Uranium in Drinking Water.

Authors:  Laura Corlin; Tommy Rock; Jamie Cordova; Mark Woodin; John L Durant; David M Gute; Jani Ingram; Doug Brugge
Journal:  Curr Environ Health Rep       Date:  2016-12

Review 4.  Lessons Learned from Arsenic Mitigation among Private Well Households.

Authors:  Yan Zheng
Journal:  Curr Environ Health Rep       Date:  2017-09

5.  Prenatal arsenic exposure and the epigenome: altered microRNAs associated with innate and adaptive immune signaling in newborn cord blood.

Authors:  Julia E Rager; Kathryn A Bailey; Lisa Smeester; Sloane K Miller; Joel S Parker; Jessica E Laine; Zuzana Drobná; Jenna Currier; Christelle Douillet; Andrew F Olshan; Marisela Rubio-Andrade; Miroslav Stýblo; Gonzalo García-Vargas; Rebecca C Fry
Journal:  Environ Mol Mutagen       Date:  2013-12-10       Impact factor: 3.216

6.  Lifetime exposure to arsenic in drinking water and bladder cancer: a population-based case-control study in Michigan, USA.

Authors:  Jaymie R Meliker; Melissa J Slotnick; Gillian A AvRuskin; David Schottenfeld; Geoffrey M Jacquez; Mark L Wilson; Pierre Goovaerts; Alfred Franzblau; Jerome O Nriagu
Journal:  Cancer Causes Control       Date:  2010-01-19       Impact factor: 2.506

7.  Validity of spatial models of arsenic concentrations in private well water.

Authors:  Jaymie R Meliker; Gillian A AvRuskin; Melissa J Slotnick; Pierre Goovaerts; David Schottenfeld; Geoffrey M Jacquez; Jerome O Nriagu
Journal:  Environ Res       Date:  2007-10-17       Impact factor: 6.498

8.  Genetic variation in glutathione S-transferase omega-1, arsenic methyltransferase and methylene-tetrahydrofolate reductase, arsenic exposure and bladder cancer: a case-control study.

Authors:  Jennifer L Beebe-Dimmer; Priyanka T Iyer; Jerome O Nriagu; Greg R Keele; Shilpin Mehta; Jaymie R Meliker; Ethan M Lange; Ann G Schwartz; Kimberly A Zuhlke; David Schottenfeld; Kathleen A Cooney
Journal:  Environ Health       Date:  2012-06-29       Impact factor: 5.984

9.  Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis.

Authors:  Jaymie R Meliker; Robert L Wahl; Lorraine L Cameron; Jerome O Nriagu
Journal:  Environ Health       Date:  2007-02-02       Impact factor: 5.984

10.  Water quality monitoring records for estimating tap water arsenic and nitrate: a validation study.

Authors:  Susan Searles Nielsen; Carrie M Kuehn; Beth A Mueller
Journal:  Environ Health       Date:  2010-01-28       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.